Understanding how certain brain receptors work and can be targeted for treatment
Quantitative analysis of metabotropic glutamate receptor activation and modulation
This study is exploring how certain brain receptors work, which could help find better treatments for conditions like fragile X syndrome and epilepsy, so patients can look forward to new therapies that improve their lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11065308 on NIH RePORTER |
What this research studies
This research focuses on metabotropic glutamate receptors (mGluRs), which are important for signaling in the brain and are potential targets for treating neurological disorders like fragile X syndrome and epilepsy. The researchers will develop a new technology to observe these receptors in real-time under physiological conditions, allowing them to see how these proteins change shape and activate signaling pathways. By understanding these mechanisms better, the research aims to identify new drug targets that could lead to improved treatments for various conditions. Patients may benefit from advancements in therapies targeting these receptors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with neurological disorders such as fragile X syndrome, epilepsy, or anxiety.
Not a fit: Patients with conditions unrelated to the functioning of metabotropic glutamate receptors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for neurological disorders and improve patient outcomes.
How similar studies have performed: Other research has shown promise in targeting GPCRs for drug development, indicating that this approach could lead to significant advancements.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Vafabakhsh, Reza — Northwestern University
- Study coordinator: Vafabakhsh, Reza
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.